Soluble CD30 levels in plasma and cerebrospinal fluid in multiple sclerosis, HIV infection and other nervous system diseases

Acta Neurologica Scandinavica

Volumn 95, Issue 2, 1997, Pages 99-102

  Navikas, V ^a   Martin, C ^a   Matusevicius, D ^a   Soderstrom M ^a   Fredrikson, S ^a   Link, H ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

cerebrospinal fluid; HIV infection; multiple sclerosis; plasma; soluble CD30

Indexed keywords

CD30 ANTIGEN; TUMOR NECROSIS FACTOR;

ADULT; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; FEMALE; HELPER CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MALE; MULTIPLE SCLEROSIS; PROGNOSIS;

EID: 0031018938     PISSN: 00016314     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0404.1997.tb00077.x     Document Type: Article

References (17)

1. FALINI B, PILERI S, PIZZOLO G et al. CD30 (Ki-1) molecule: a new cytokine receptor of the tumor necrosis receptor superfamily as a tool for diagnosis and immunotherapy. Blood 1995: 85: 1-14.
2. JOSIMOVIC-ALASEVIC O, DURKOP H, SCHWARTING R, et al. Ki-1 (CD30) antigen is released by Ki-1-positive tumor cells in vitro and vivo. I. Partial characterisation of soluble Ki-1 antigen and detection of the antigen in cell culture supernatants and in serum by an enzyme-linked immunosorbent assay. Eur J Immunol 1989: 19: 157-62.
3. ANDREESEN R, OSTERHOLZ J, LOHR GW, BROSS KJ. A Hodgkin cell-specific antigen is expressed on a subset of auto- and alloactivated T (helper) lymphoblasts. Blood 1984: 63: 1299-302.
4. SMITH CA, GRUSS H-J, DAVIS T et al. CD30 antigen, a marker for Hodgkin's lymphoma is a receptor whose ligand defines an emerging family of cytokines with homology to TNF. Cell 1993: 73: 1349-60.
5. + T cell clones in human immunodeficiency virus infection. J Exp Med 1994: 180: 2407-11.
6. DEL PRETE G, DECARLI M, DELIOS MM et al. CD30-mediated signalling promotes the development of human T helper type 2-like cells. J Exp Med 1995: 182: 1655-61.
7. PIZZOLO G, VINANTE F, MOROSATO L et al. High serum levels of the soluble form of CD30 molecule in the early phase of HIV-1 infection as an independent predictor to progression to AIDS. AIDS 1994: 8: 741-5.
8. CALIGARISCAPPIO F, BERTERO MT, CONVERSO M et al. Circulating levels of soluble CD30, a marker of cells producing Th2 cytokines, are increased in patients with systemic lupus erythematosus and correlate with disease activity. Clin Exp Rheumatol 1995: 13: 339-43.
9. + T cells producing Th2-type cytokines. FASEB J 1995: 9: 81-6.
10. DEL PRETE G, MAGGI E, PIZZOLO G, ROMAGNANI S. CD30, Th2 cytokines and HIV infection: a complex and fascinating link. Immunol Today 1995: 16: 76-80.
11. ROMAGNANI S, DEL PRETE G, MAGGI E, CHILOSI M, CALIGARIS-CAPPIO F, PIZZOLO G. CD30 and type 2 T helper (Th2) responses. J Leukoc Biol 1995: 57: 726-30.
12. FATTOVICH G, VINANTE F, GIUSTTNA G et al. Serum levels of soluble CD30 in chronic hepatitis B virus infection. Clin Exp Immunol 1996: 103: 105-10.
13. SCHUMACHER GA, BEEBE G, KIBLER RF et al. Problems of experimental trials of therapy in multiple sclerosis: report by the panel on the evaluation of experimental trials of therapy in multiple sclerosis. Ann N Y Acad Sci 1965: 122: 552-68.
14. KURTZKE JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983: 33: 1444-52.
15. TIBBLING G, LINK H, ÖHMAN S. Principles of albumin and IgG analyses in neurological disorders. I. Establishment of reference values. Scand J Clin Lab Invest 1977: 37: 385-90.
16. OLSSON T, KOSTULAS V, LINK H. Improved detection of oligoclonal IgG in cerebrospinal fluid by isoelectric focusing in agarose, double antibody peroxidase labelling, and avidin-biotin amplification. Clin Chem 1984: 30: 1246-9.
17. Centers for Disease Control: 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS in adolescents and adults. MMWR Morb Mortal Wkly Rep 1992: 41(RR-17): 1-13.